{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:02:54Z","timestamp":1781067774149,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.hrtlng.2025.11.013","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T10:41:00Z","timestamp":1763894460000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Medication management, health outcomes, and economic burden of severe asthma stratified by asthma control levels"],"prefix":"10.1016","volume":"76","author":[{"given":"Ke","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6012-2785","authenticated-orcid":false,"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2025.11.013_bib0001","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","article-title":"Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"5","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0004","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.98.12061322","article-title":"Costs of asthma according to the degree of severity","volume":"12","author":"Serra-Batlles","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1183\/09031936.02.00232001","article-title":"Costs of asthma are correlated with severity: a 1-yr prospective study","volume":"19","author":"Godard","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0006","first-page":"1023","article-title":"[Guidelines for bronchial asthma prevent and management(2020 edition) Asthma group of Chinese Throacic Society]","volume":"43","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0007","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.anai.2021.07.010","article-title":"Severe asthma exacerbations in the United States:: incidence, characteristics, predictors, and effects of biologic treatments","volume":"127","author":"Trevor","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.anai.2016.07.020","article-title":"Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire","volume":"117","author":"Sullivan","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0009","article-title":"Asthma control is associated with economic outcomes, work productivity and health-related quality of life in patients with asthma","volume":"7","author":"Lee","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106670","article-title":"A systematic literature review of burden of illness in adults with uncontrolled moderate\/severe asthma","volume":"191","author":"Czira","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0011","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the international severe asthma registry","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100662","article-title":"Economic burden of severe asthma treatment: a real-life study","volume":"15","author":"L\u00f3pez-Tiro","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.resinv.2021.02.010","article-title":"Real-world treatment and health care resource use among severe asthma patients in Japan","volume":"59","author":"To","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0014","series-title":"China Health Statistical Yearbook 2022","year":"2022"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0016","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American thoracic society\/European respiratory society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0017","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.37765\/ajmc.2022.89159","article-title":"Clinical and economic burden of uncontrolled severe noneosinophilic asthma","volume":"28","author":"Tan","year":"2022","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060160","article-title":"Real-life impact of uncontrolled severe asthma on mortality and healthcare use in adolescents and adults: findings from the retrospective, observational RESONANCE study in France","volume":"12","author":"Roche","year":"2022","journal-title":"Bmj Open"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0019","article-title":"Investigation on current situation of Chinese patent medicines for children in China based on the national drug coding database","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0020","article-title":"Traditional Chinese medicine-coding system for Chinese medicines-part 1: coding rules for Chinese medicines","year":"2016","journal-title":"ISO"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0021","first-page":"917","article-title":"A cross-section study of severe asthma in eight provinces of China","volume":"55","author":"Su","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0022","first-page":"1106","article-title":"A survey on clinical characteristics and risk factors of severe asthma in China","volume":"100","author":"Wang","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0023","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.21037\/jtd.2017.04.74","article-title":"Severe and uncontrolled asthma in China: a cross-sectional survey from the Australasian Severe Asthma Network","volume":"9","author":"Wang","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00069-2019","article-title":"FASE-CPHG study: a panoramic snapshot of difficult-to-treat, severe asthma in French nonacademic hospitals","volume":"5","author":"Portel","year":"2019","journal-title":"ERJ open res"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/JAA.S391970","article-title":"A multi-center study of the prevalence and characteristics of eosinophilic phenotype and high IgE levels among Chinese patients with severe asthma","volume":"16","author":"Ko","year":"2023","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/JAA.S378505","article-title":"A retrospective claims database study to clarify disease burden of severe asthma patients with type 2 high or low inflammation","volume":"16","author":"Harada","year":"2023","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0027","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/13696998.2020.1719118","article-title":"Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain","volume":"23","author":"Sicras-Mainar","year":"2020","journal-title":"J Med Econ"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0028","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2147\/JAA.S377174","article-title":"Characterization of patients in the international severe asthma Registry with high steroid exposure who did or did not initiate biologic therapy","volume":"15","author":"Chen","year":"2022","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/02770903.2019.1708095","article-title":"Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study","volume":"58","author":"M\u00fcllerov\u00e1","year":"2021","journal-title":"J Asthma 2F: Off J Assoc Care Asthma"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0030","first-page":"62","article-title":"Inhaled corticosteroid-phobia and childhood asthma: current understanding and management implications","volume":"33","author":"Hui","year":"2020","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0031","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/pds.2228","article-title":"Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study","volume":"20","author":"Koster","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0032","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1542\/peds.2006-3023","article-title":"The impact of parents\u2019 medication beliefs on asthma management","volume":"120","author":"Conn","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0033","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2431-13-20","article-title":"The knowledge, attitudes and practices of parents of children with asthma in 29 cities of China: a multi-center study","volume":"13","author":"Zhao","year":"2013","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0034","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0035","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1097\/CM9.0000000000001680","article-title":"Asthma treatment adherence and related factors in Shanghai, China","volume":"134","author":"Du","year":"2021","journal-title":"Chin Med J"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0036","series-title":"Statistical Bulletin On The Development Of China\u2019s Health Undertakings in 2020","year":"2024"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0037","article-title":"Centers for medicare & medicaid services","year":"2024","journal-title":"Natl Health Expend Data"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41533-019-0128-8","article-title":"A retrospective cohort study evaluating healthcare resource utilization in patients with asthma in Japan","volume":"29","author":"Inoue","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0039","series-title":"World Bank Open Data","year":"2024"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0040","article-title":"Economic burden of illness among patients with severe asthma in a managed care setting","volume":"22","author":"Chastek","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0041","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1183\/13993003.01303-2015","article-title":"Asthma education: an essential component in asthma management","volume":"46","author":"Boulet","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0042","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.3390\/jcm11236985","article-title":"Medication adherence in Medicare-enrolled older adults with chronic obstructive pulmonary disease before and during the COVID-19 Pandemic","volume":"11","author":"Liu","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0043","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/heapol\/czaa087","article-title":"The association between an increased reimbursement cap for chronic disease coverage and healthcare utilization in China: an interrupted time series study","volume":"35","author":"Shen","year":"2020","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.hrtlng.2025.11.013_bib0044","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-087190","article-title":"Systematic review of the impact of the National Medication Price negotiated Policy on the accessibility of drugs in China, 2016-2024","volume":"14","author":"Peng","year":"2024","journal-title":"BMJ Open"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956325002626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956325002626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:54:24Z","timestamp":1781067264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956325002626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"alternative-id":["S0147956325002626"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2025.11.013","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication management, health outcomes, and economic burden of severe asthma stratified by asthma control levels","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2025.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}